mafba is a downstream transcriptional effector of vegfc signaling essential for embryonic lymphangiogenesis in zebrafish

Genes and Development

Volumn 29, Issue 15, 2015, Pages 1618-1630

  Koltowska, Katarzyna ^a   Paterson, Scott ^a   Bower, Neil I ^a   Baillie, Gregory J ^a   Lagendijk, Anne K ^a   Astin, Jonathan W ^b   Chen, Huijun ^a   Francois, Mathias ^a   Crosier, Philip S ^b   Taft, Ryan J ^a   Simons, Cas ^a   Smith, Kelly A ^a   Hogan, Benjamin M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Lymphatic; Mafb; Sox18; Sox7; Vascular; Vegfc; Zebrafish

Indexed keywords

TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR MAFBA; TRANSCRIPTION FACTOR SOX; UNCLASSIFIED DRUG; VASCULOTROPIN C; MAFB PROTEIN, ZEBRAFISH; NERVE PROTEIN; VASCULOTROPIN RECEPTOR 3; ZEBRAFISH PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO (ANATOMY); EMBRYO DEVELOPMENT; ENDOTHELIUM; LYMPHANGIOGENESIS; NONHUMAN; PERIPHERAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPROUT; SPROUTING; VEIN; ANIMAL; ANIMAL EMBRYO; CELL MOTION; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; LYMPH VESSEL; METABOLISM; MUTATION; ZEBRA FISH;

DANIO RERIO;

ANIMALS; CELL MOVEMENT; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MAFB TRANSCRIPTION FACTOR; MUTATION; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84938880467     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.263210.115     Document Type: Article

References (77)

1. Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF, Offerhaus GJ, et al. 2009. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 41: 1272–1274
2. Artner I, Blanchi B, Raum JC, Guo M, Kaneko T, Cordes S, Sieweke M, Stein R. 2007. MafB is required for islet β cell maturation. Proc Natl Acad Sci 104: 3853–3858
3. Astin JW, Haggerty MJ, Okuda KS, Le Guen L, Misa JP, Tromp A, Hogan BM, Crosier KE, Crosier PS. 2014. Vegfd can compensate for loss of Vegfc in zebrafish facial lymphatic sprouting. Development 141: 2680–2690
4. Bakri Y, Sarrazin S, Mayer UP, Tillmanns S, Nerlov C, Boned A, Sieweke MH. 2005. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 105: 2707–2716
5. Bos FL, Caunt M, Peterson-Maduro J, Planas-Paz L, Kowalski J, Karpanen T, van Impel A, Tong R, Ernst JA, Korving J, et al. 2011. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ Res 109: 486–491
6. Bussmann J, Bos FL, Urasaki A, Kawakami K, Duckers HJ, Schulte-Merker S. 2010. Arteries provide essential guidance cues for lymphatic endothelial cells in the zebrafish trunk. Development 137: 2653–2657
7. Cermenati S, Moleri S, Cimbro S, Corti P, Del Giacco L, Amodeo R, Dejana E, Koopman P, Cotelli F, Beltrame M. 2008. Sox18 and Sox7 play redundant roles in vascular development. Blood 111: 2657–2666
8. Cha YR, Fujita M, Butler M, Isogai S, Kochhan E, Siekmann AF, Weinstein BM. 2012. Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature. Dev Cell 22: 824–836
9. Connell F, Kalidas K, Ostergaard P, Brice G, Homfray T, Roberts L, Bunyan DJ, Mitton S, Mansour S, Mortimer P, et al. 2010. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia. Hum Genet 127: 231–241
10. Cooke JE, Xu QL, Wilson SW, Holder N. 1997. Characterisation of five novel zebrafish Eph-related receptor tyrosine kinases suggests roles in patterning the neural plate. Dev Genes Evol 206: 515–531
11. Coxam B, Sabine A, Bower NI, Smith KA, Pichol-Thievend C, Skoczylas R, Astin JW, Frampton E, Jaquet M, Crosier PS, et al. 2014. Pkd1 regulates lymphatic vascular morphogenesis during development. Cell Rep 7: 623–633
12. Coxam B, Neyt C, Grassini DR, Le Guen L, Smith KA, Schulte- Merker S, Hogan BM. 2015 Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish. Dev Dyn 244: 1–9
13. de Bruijn E, Cuppen E, Feitsma H. 2009. Highly efficient ENU mutagenesis in zebrafish. Methods Mol Biol 546: 3–12
14. Deng Y, Atri D, Eichmann A, Simons M. 2013. Endothelial ERK signaling controls lymphatic fate specification. J Clin Invest 123: 1202–1215
15. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946–949
16. Dunworth WP, Cardona-Costa J, Bozkulak EC, Kim JD, Meadows S, Fischer JC, Wang Y, Cleaver O, Qyang Y, Ober EA, et al. 2014. Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos. Circ Res 114: 56–66
17. Duong T, Koltowska K, Pichol-Thievend C, Le Guen L, Fontaine F, Smith KA, Truong V, Skoczylas R, Stacker SA, Achen MG, et al. 2014. VEGFD regulates blood vascular development by modulating SOX18 activity. Blood 123: 1102–1112
18. Durbin L, Brennan C, Shiomi K, Cooke J, Barrios A, Shanmugalingam S, Guthrie B, Lindberg R, Holder N. 1998. Eph signaling is required for segmentation and differentiation of the somites. Genes Dev 12: 3096–3109
19. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. 2000. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67: 1382–1388
20. Finegold DN, Kimak MA, Lawrence EC, Levinson KL, Cherniske EM, Pober BR, Dunlap JW, Ferrell RE. 2001. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 10: 1185–1189
21. Francois M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M, et al. 2008. Sox18 induces development of the lymphatic vasculature in mice. Nature 456: 643–647
22. Gagnon JA, Valen E, Thyme SB, Huang P, Ahkmetova L, Pauli A, Montague TG, Zimmerman S, Richter C, Schier AF. 2014. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. PLoS One 9: e98186
23. Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG, van Impel A, Connell F, Kalidas K, Jeffery S, Mortimer PS, et al. 2013. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res 112: 956–960
24. Hagerling R, Pollmann C, Andreas M, Schmidt C, Nurmi H, Adams RH, Alitalo K, Andresen V, Schulte-Merker S, Kiefer F. 2013. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J 32: 629–644
25. Hartley JL, Temple GF, Brasch MA. 2000. DNA cloning using in vitro site-specific recombination. Genome Res 10: 1788–1795
26. Helker CS, Schuermann A, Karpanen T, Zeuschner D, Belting HG, Affolter M, Schulte-Merker S, Herzog W. 2013. The zebrafish common cardinal veins develop by a novel mechanism: lumen ensheathment. Development 140: 2776–2786
27. Hermkens DM, van Impel A, Urasaki A, Bussmann J, Duckers HJ, Schulte-Merker S. 2015. Sox7 controls arterial specification in conjunction with hey2 and efnb2 function. Development 142: 1695–1704
28. Herpers R, van de Kamp E, Duckers HJ, Schulte-Merker S. 2008. Redundant roles for sox7 and sox18 in arteriovenous specification in zebrafish. Circ Res 102: 12–15
29. Hogan BM, Bos FL, Bussmann J, Witte M, Chi NC, Duckers HJ, Schulte-Merker S. 2009a. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41: 396–398
30. Hogan BM, Herpers R, Witte M, Helotera H, Alitalo K, Duckers HJ, Schulte-Merker S. 2009b. Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries. Development 136: 4001–4009
31. Hosking B, Francois M, Wilhelm D, Orsenigo F, Caprini A, Svingen T, Tutt D, Davidson T, Browne C, Dejana E, et al. 2009. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice. Development 136: 2385–2391
32. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67: 295–301
33. Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Steijlen PM, Fryns JP, Van Steensel MA, Vikkula M. 2003. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema- telangiectasia. Am J Hum Genet 72: 1470–1478
34. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423–1425
35. Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Leppanen VM, Holopainen T, Kivela R, Ortega S, Karpanen T, Alitalo K. 2014. CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation. Circulation 129: 1962–1971
36. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. 2005. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132: 5199–5209
37. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25: 153–159
38. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, et al. 2001. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci 98: 12677–12682
39. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, et al. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74–80
40. Kartopawiro J, Bower NI, Karnezis T, Kazenwadel J, Betterman KL, Lesieur E, Koltowska K, Astin J, Crosier P, Vermeren S, et al. 2014. Arap3 is dysregulated in a mouse model of hypotrichosis- lymphedema-telangiectasia and regulates lymphatic vascular development. Hum Mol Genet 23: 1286–1297
41. Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar- Rodriguez J, Hsu AP, Dyack S, Fernandez CV, Chong CE, et al. 2012. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 119: 1283–1291
42. Kelly LM, Englmeier U, Lafon I, Sieweke MH, Graf T. 2000. MafB is an inducer of monocytic differentiation. EMBO J 19: 1987–1997
43. Koltowska K, Betterman KL, Harvey NL, Hogan BM. 2013. Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature. Development 140: 1857–1870
44. Kuchler AM, Gjini E, Peterson-Maduro J, Cancilla B, Wolburg H, Schulte-Merker S. 2006. Development of the zebrafish lymphatic system requires VEGFC signaling. Curr Biol 16: 1244–1248
45. Lawson ND, Weinstein BM. 2002. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248: 307–318
46. Le Guen L, Karpanen T, Schulte D, Harris NC, Koltowska K, Roukens G, Bower NI, van Impel A, Stacker SA, Achen MG, et al. 2014. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis. Development 141: 1239–1249
47. Leshchiner I, Alexa K, Kelsey P, Adzhubei I, Austin-Tse CA, Cooney JD, Anderson H, King MJ, Stottmann RW, Garnaas MK, et al. 2012. Mutation mapping and identification by whole-genome sequencing. Genome Res 22: 1541–1548
48. Lim KC, Hosoya T, Brandt W, Ku CJ, Hosoya-Ohmura S, Camper SA, Yamamoto M, Engel JD. 2012. Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest 122: 3705–3717
49. Lim HY, Thiam CH, Yeo KP, Bisoendial R, Hii CS, McGrath KC, Tan KW, Heather A, Alexander JS, Angeli V. 2013. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab 17: 671–684
50. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, et al. 2001. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor- 3. Nat Med 7: 199–205
51. Martel C, Li W, Fulp B, Platt AM, Gautier EL, Westerterp M, Bittman R, Tall AR, Chen SH, Thomas MJ, et al. 2013. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 123: 1571–1579
52. Moens CB, Prince VE. 2002. Constructing the hindbrain: insights from the zebrafish. Dev Dyn 224: 1–17
53. Moens CB, Yan YL, Appel B, Force AG, Kimmel CB. 1996. valentino: a zebrafish gene required for normal hindbrain segmentation. Development 122: 3981–3990
54. Moens CB, Cordes SP, Giorgianni MW, Barsh GS, Kimmel CB. 1998. Equivalence in the genetic control of hindbrain segmentation in fish and mouse. Development 125: 381–391
55. Moriguchi T, Hamada M, Morito N, Terunuma T, Hasegawa K, Zhang C, Yokomizo T, Esaki R, Kuroda E, Yoh K, et al. 2006. MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol 26: 5715–5727
56. Norrmen C, Ivanov KI, Cheng J, Zangger N, Delorenzi M, Jaquet M, Miura N, Puolakkainen P, Horsley V, Hu J, et al. 2009. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 185: 439–457
57. Ober EA, Olofsson B, Makinen T, Jin SW, Shoji W, Koh GY, Alitalo K, Stainier DY. 2004. Vegfc is required for vascular development and endoderm morphogenesis in zebrafish. EMBO Rep 5: 78–84
58. Okuda KS, Astin JW, Misa JP, Flores MV, Crosier KE, Crosier PS. 2012. lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. Development 139: 2381–2391
59. Oliver G, Srinivasan RS. 2010. Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell. Development 137: 363–372
60. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, et al. 2011. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43: 929–931
61. Pendeville H, Winandy M, Manfroid I, Nivelles O, Motte P, Pasque V, Peers B, Struman I, Martial JA, Voz ML. 2008. Zebrafish Sox7 and Sox18 function together to control arterial-venous identity. Dev Biol 317: 405–416
62. Petrova TV, Karpanen T, Norrmen C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Yla-Herttuala S, et al. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10: 974–981
63. Pham VN, Lawson ND, Mugford JW, Dye L, Castranova D, Lo B, Weinstein BM. 2007. Combinatorial function of ETS transcription factors in the developing vasculature. Dev Biol 303: 772–783
64. Sadl V, Jin F, Yu J, Cui S, Holmyard D, Quaggin S, Barsh G, Cordes S. 2002. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev Biol 249: 16–29
65. Schulte-Merker S, Sabine A, Petrova TV. 2011. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol 193: 607–618
66. Sieweke MH, Tekotte H, Frampton J, Graf T. 1996. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 85: 49–60
67. Sieweke MH, Tekotte H, Frampton J, Graf T. 1997. MafB represses erythroid genes and differentiation through direct interaction with c-Ets-1. Leukemia 11(Suppl 3): 486–488
68. Srinivasan RS, Oliver G. 2011. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev 25: 2187–2197
69. Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S, Studer M, Porto MP, Lagutin O, Oliver G. 2010. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 24: 696–707
70. Srinivasan RS, Escobedo N, Yang Y, Interiano A, Dillard ME, Finkelstein D, Mukatira S, Gil HJ, Nurmi H, Alitalo K, et al. 2014. The Prox1–Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev 28: 2175–2187
71. Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. 2014. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14: 159–172
72. van Impel A, Zhao Z, Dorien MA, Hermkens M, Roukens G, Fischer JC, Peterson-Maduro J, Duckers H, Ober EA, Ingham PW, et al. 2014. Divergence of zebrafish and mouse lymphatic cell fate specification pathways. Development 141: 1228–1238
73. Villefranc JA, Nicoli S, Bentley K, Jeltsch M, Zarkada G, Moore JC, Gerhardt H, Alitalo K, Lawson ND. 2013. A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development. Development 140: 1497–1506
74. Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769–778
75. Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. 2006. Live imaging of lymphatic development in the zebrafish. Nat Med 12: 711–716
76. Yoshimatsu Y, Yamazaki T, Mihira H, Itoh T, Suehiro J, Yuki K, Harada K, Morikawa M, Iwata C, Minami T, et al. 2011. Etsfamily members induce lymphangiogenesis through physical and functional interaction with Prox1. J Cell Sci 124: 2753–2762
77. Zheng W, Aspelund A, Alitalo K. 2014. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest 124: 878–887